ATRC
Price
$31.76
Change
+$0.37 (+1.18%)
Updated
Jul 3 closing price
Capitalization
1.45B
30 days until earnings call
SIBN
Price
$18.47
Change
+$0.04 (+0.22%)
Updated
Jul 3 closing price
Capitalization
672.23M
36 days until earnings call
Interact to see
Advertisement

ATRC vs SIBN

Header iconATRC vs SIBN Comparison
Open Charts ATRC vs SIBNBanner chart's image
AtriCure
Price$31.76
Change+$0.37 (+1.18%)
Volume$166.07K
Capitalization1.45B
SI-BONE
Price$18.47
Change+$0.04 (+0.22%)
Volume$288.62K
Capitalization672.23M
ATRC vs SIBN Comparison Chart in %
Loading...
ATRC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SIBN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATRC vs. SIBN commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATRC is a Hold and SIBN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 07, 2025
Stock price -- (ATRC: $31.76 vs. SIBN: $18.47)
Brand notoriety: ATRC and SIBN are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: ATRC: 28% vs. SIBN: 55%
Market capitalization -- ATRC: $1.45B vs. SIBN: $672.23M
ATRC [@Medical Specialties] is valued at $1.45B. SIBN’s [@Medical Specialties] market capitalization is $672.23M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATRC’s FA Score shows that 0 FA rating(s) are green whileSIBN’s FA Score has 0 green FA rating(s).

  • ATRC’s FA Score: 0 green, 5 red.
  • SIBN’s FA Score: 0 green, 5 red.
According to our system of comparison, SIBN is a better buy in the long-term than ATRC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATRC’s TA Score shows that 4 TA indicator(s) are bullish while SIBN’s TA Score has 6 bullish TA indicator(s).

  • ATRC’s TA Score: 4 bullish, 6 bearish.
  • SIBN’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, SIBN is a better buy in the short-term than ATRC.

Price Growth

ATRC (@Medical Specialties) experienced а -3.41% price change this week, while SIBN (@Medical Specialties) price change was +2.10% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.95%. For the same industry, the average monthly price growth was +1.48%, and the average quarterly price growth was -0.02%.

Reported Earning Dates

ATRC is expected to report earnings on Aug 05, 2025.

SIBN is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Medical Specialties (+1.95% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ATRC($1.45B) has a higher market cap than SIBN($672M). SIBN YTD gains are higher at: 31.740 vs. ATRC (3.927). ATRC has higher annual earnings (EBITDA): -8.11M vs. SIBN (-34.45M). SIBN has more cash in the bank: 166M vs. ATRC (137M). SIBN has less debt than ATRC: SIBN (39M) vs ATRC (74.5M). ATRC has higher revenues than SIBN: ATRC (399M) vs SIBN (139M).
ATRCSIBNATRC / SIBN
Capitalization1.45B672M215%
EBITDA-8.11M-34.45M24%
Gain YTD3.92731.74012%
P/E Ratio36.76N/A-
Revenue399M139M287%
Total Cash137M166M83%
Total Debt74.5M39M191%
FUNDAMENTALS RATINGS
ATRC vs SIBN: Fundamental Ratings
ATRC
SIBN
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
70
Overvalued
43
Fair valued
PROFIT vs RISK RATING
1..100
10099
SMR RATING
1..100
9393
PRICE GROWTH RATING
1..100
5743
P/E GROWTH RATING
1..100
97100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SIBN's Valuation (43) in the Medical Specialties industry is in the same range as ATRC (70). This means that SIBN’s stock grew similarly to ATRC’s over the last 12 months.

SIBN's Profit vs Risk Rating (99) in the Medical Specialties industry is in the same range as ATRC (100). This means that SIBN’s stock grew similarly to ATRC’s over the last 12 months.

SIBN's SMR Rating (93) in the Medical Specialties industry is in the same range as ATRC (93). This means that SIBN’s stock grew similarly to ATRC’s over the last 12 months.

SIBN's Price Growth Rating (43) in the Medical Specialties industry is in the same range as ATRC (57). This means that SIBN’s stock grew similarly to ATRC’s over the last 12 months.

ATRC's P/E Growth Rating (97) in the Medical Specialties industry is in the same range as SIBN (100). This means that ATRC’s stock grew similarly to SIBN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ATRCSIBN
RSI
ODDS (%)
N/A
Bullish Trend 17 days ago
72%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
74%
Bearish Trend 4 days ago
80%
Momentum
ODDS (%)
Bullish Trend 4 days ago
75%
Bullish Trend 4 days ago
83%
MACD
ODDS (%)
Bearish Trend 4 days ago
80%
Bullish Trend 4 days ago
78%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
82%
Bullish Trend 4 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
79%
Bearish Trend 4 days ago
80%
Advances
ODDS (%)
Bullish Trend 20 days ago
73%
Bullish Trend 7 days ago
79%
Declines
ODDS (%)
Bearish Trend 5 days ago
84%
Bearish Trend 17 days ago
79%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
89%
Bullish Trend 4 days ago
76%
Aroon
ODDS (%)
Bullish Trend 4 days ago
70%
Bearish Trend 4 days ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
ATRC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SIBN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PSMLX29.190.21
+0.72%
Principal SmallCap R6
LIFLX14.910.10
+0.68%
Lord Abbett Focused Large Cap Value I
APFDX22.360.13
+0.58%
Artisan Global Discovery Investor
UBVCX75.660.42
+0.56%
Undiscovered Managers Behavioral Val C
HWAAX40.740.17
+0.42%
Hotchkis & Wiley Value Opps A

ATRC and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATRC has been loosely correlated with IRMD. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if ATRC jumps, then IRMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATRC
1D Price
Change %
ATRC100%
+1.18%
IRMD - ATRC
42%
Loosely correlated
+0.42%
SIBN - ATRC
42%
Loosely correlated
+0.22%
NVST - ATRC
39%
Loosely correlated
+1.09%
TMCI - ATRC
39%
Loosely correlated
+1.48%
KIDS - ATRC
38%
Loosely correlated
+1.54%
More

SIBN and

Correlation & Price change

A.I.dvisor indicates that over the last year, SIBN has been loosely correlated with AORT. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if SIBN jumps, then AORT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SIBN
1D Price
Change %
SIBN100%
+0.22%
AORT - SIBN
47%
Loosely correlated
-0.42%
TMCI - SIBN
44%
Loosely correlated
+1.48%
UFPT - SIBN
44%
Loosely correlated
+1.52%
KIDS - SIBN
42%
Loosely correlated
+1.54%
ATRC - SIBN
42%
Loosely correlated
+1.18%
More